Phase 2 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 or older.
- People with non-small cell lung cancer whose cancer has spread to the lungs after previously receiving a type of cancer treatment called PD-1 immunotherapy.
- People who are willing to take part in the study and sign a consent form agreeing to participate.
- People who have lung metastases (areas of cancer in the lungs) that can be measured in size and number on a chest CT scan.
- People for whom a needle biopsy of the lung is considered appropriate by their doctor.
- People who are in good general physical condition, rated 0 or 1 on a standard health scale used by doctors (meaning fully active or able to carry out light activity).
- People whose blood test results meet specific requirements, including acceptable levels of white blood cells, neutrophils, platelets, haemoglobin, clotting factors, bilirubin, liver enzymes, and kidney function (confirm exact values with trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are unable to tolerate further immunotherapy, or who do not wish to receive it.
- People who belong to vulnerable groups, including those with a mental illness, cognitive impairment, critical illness, anyone under 18, pregnant women, or those who are unable to read or write.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
tumor response rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.